Patent · US Expired

Pharmaceutical compounds

US7186753B1 · kind B1 · utility

22Cited by
4References
18Claims
0Family size

Assignee

Inventor

Key dates

Filing dateJul 27, 2000
Grant dateMar 6, 2007
Priority date
Expiry dateApr 9, 2021

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C2602/08
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds or their salts of general formula (I): A—B—N(O)s wherein: s is an integer equal to 1 or 2; A=R—T1—, wherein R is the drug radical and T1=(CO)t or (X)t′, wherein X=O, S, NR1c, R1c is H or a linear or branched alkyl or a free valence, t and t′ are integers and equal to zero or 1, with the proviso that t=1 when t′=0; t=0 when t′=1; B=—TB—X2—O— wherein TB=(CO) when t=0, TB=X when t′=0, X being as above defined; X2 is equal to R1B—X—R2B radical wherein X is as above defined, R1B and R2B, equal to or different from each other, are linear or branched C1–C6 alkylenes, or X2 is a radical wherein two alkylene chains C1–C4 are linked to nonadjacent positions of a central ring having 4 or 6 atoms, said ring being an unsaturated cycloaliphatic ring, or a saturated or aromatic heterocylic ring, containing one or two heteroatoms, equal or different, selected from O, S, N; wherein the unsaturated cycloaliphatic ring does not have aromatic character according to Huckel's rule.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.